Werner Rittgen

Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG

Dirk Schadendorf, Selma Ugurel, Beatrice Schuler‐Thurner et al. · Annals of Oncology · 2006 · 466 citations · Full text

Cancer Immunosurveillance, Medicine, Melanoma +9

Lack of clinical efficacy of imatinib in metastatic melanoma

Selma Ugurel, Ralf Hildenbrand, A Zimpfer et al. · British Journal of Cancer · 2005 · 241 citations · Full text

Prognostic value of ERBB-1, VEGF, cyclin A, FOS, JUN and MYC in patients with squamous cell lung carcinomas

M Volm, Werner Rittgen, P. Drings · British Journal of Cancer · 1998 · 178 citations · Full text

Medicine, Prognostic Value, Pathology +6

Primary staging and follow-up in melanoma patients – monocenter evaluation of methods, costs and patient survival

U. Hofmann, M Szedlak, Werner Rittgen et al. · British Journal of Cancer · 2002 · 157 citations · Full text

Surgical Oncology, Cancer Management, Pathology +20

B-RAF and N-RAS Mutations Are Preserved during Short Time In Vitro Propagation and Differentially Impact Prognosis

Selma Ugurel, Ranjit K. Thirumaran, Sandra Bloethner et al. · PLoS ONE · 2007 · 133 citations · Full text

Genetics, Pathology, Favorable Prognosis +19